PubMed

Precursors and preinvasive lesions of the breast: the role of molecular prognostic markers in the diagnostic and therapeutic dilemma.

Zagouri F, Sergentanis TN, Zografos GC.

World J Surg Oncol. 2007 May 31;5:57. Review.PMID: 17540032 [PubMed - indexed for MEDLINE]Related articlesFree article

Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family.

Abdel-Fatah TM, Powe DG, Hodi Z, Reis-Filho JS, Lee AH, Ellis IO.

Am J Surg Pathol. 2008 Apr;32(4):513-23.PMID: 18223478 [PubMed - indexed for MEDLINE]Related articles

High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma.

Abdel-Fatah TM, Powe DG, Hodi Z, Lee AH, Reis-Filho JS, Ellis IO.

Am J Surg Pathol. 2007 Mar;31(3):417-26.PMID: 17325484 [PubMed - indexed for MEDLINE]Related articles

The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classification.

Pinder SE, Ellis IO.

Breast Cancer Res. 2003;5(5):254-7. Epub 2003 Jul 29. Review.PMID: 12927035 [PubMed - indexed for MEDLINE]Related articlesFree article

Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis.

Simpson PT, Gale T, Reis-Filho JS, Jones C, Parry S, Sloane JP, Hanby A, Pinder SE, Lee AH, Humphreys S, Ellis IO, Lakhani SR.

Am J Surg Pathol. 2005 Jun;29(6):734-46.PMID: 15897740 [PubMed - indexed for MEDLINE]Related articles

Immunohistochemical categorisation of ductal carcinoma in situ of the breast.

Meijnen P, Peterse JL, Antonini N, Rutgers EJ, van de Vijver MJ.

Br J Cancer. 2008 Jan 15;98(1):137-42. Epub 2007 Nov 27.PMID: 18043578 [PubMed - indexed for MEDLINE]Related articlesFree article

Ductal carcinoma in situ of the breast: diagnosis and management.

Friedrich M, Felberbaum R, Krämer S, Axt-Fliedner R, Diedrich K.

Onkologie. 2003 Dec;26(6):588-95. Review.PMID: 14709936 [PubMed - indexed for MEDLINE]Related articles

Prognostic and predictive molecular markers in DCIS: a review.

Nofech-Mozes S, Spayne J, Rakovitch E, Hanna W.

Adv Anat Pathol. 2005 Sep;12(5):256-64. Review.PMID: 16210921 [PubMed - indexed for MEDLINE]Related articles

Expression of ER, Ki-67 and cylinD1 in the pre-cancerous breast of Chinese patients.

Zhou CJ, Zhang QH, Zhang TG, Sun SZ, Li H, Wang Y, Liu ZY.

Pathol Oncol Res. 2009 Jun;15(2):153-8. Epub 2008 Oct 22.PMID: 18941930 [PubMed - indexed for MEDLINE]Related articles

Molecular evolution of breast cancer.

Simpson PT, Reis-Filho JS, Gale T, Lakhani SR.

J Pathol. 2005 Jan;205(2):248-54. Review.PMID: 15641021 [PubMed - indexed for MEDLINE]Related articles

Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer.

Azizun-Nisa, Bhurgri Y, Raza F, Kayani N.

Asian Pac J Cancer Prev. 2008 Oct-Dec;9(4):553-6.PMID: 19256737 [PubMed - indexed for MEDLINE]Related articles

Impact of immunohistochemical markers, CK5/6 and E-cadherin on diagnostic agreement in non-invasive proliferative breast lesions.

MacGrogan G, Arnould L, de Mascarel I, Vincent-Salomon A, Penault-Llorca F, Lacroix-Triki M, Bibeau F, Baranzelli MC, Fridman V, Antoine M, Bécette V, Brouste V, Jacquemier J, Mathoulin-Pélissier S; GEFPICS group.

Histopathology. 2008 May;52(6):689-97. Epub 2008 Apr 5.PMID: 18397281 [PubMed - indexed for MEDLINE]Related articles

Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast.

Hanley K, Wang J, Bourne P, Yang Q, Gao AC, Lyman G, Tang P.

Hum Pathol. 2008 Mar;39(3):386-92. Epub 2008 Jan 9.PMID: 18187183 [PubMed - indexed for MEDLINE]Related articles

[Role of cytokeratin expression in differential diagnosis of intraductal proliferative lesions of breast]

Zhang JL, Zhang HY, Wei B, Lang ZQ, Bu H.

Zhonghua Bing Li Xue Za Zhi. 2004 Aug;33(4):316-9. Chinese. PMID: 15363314 [PubMed - indexed for MEDLINE]Related articles

Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy.

Rudloff U, Brogi E, Brockway JP, Goldberg JI, Cranor M, Wynveen CA, Nehhozina T, Reiner AS, Patil S, Van Zee KJ.

Cancer. 2009 Mar 15;115(6):1203-14.PMID: 19170233 [PubMed - indexed for MEDLINE]Related articlesFree article

Evolving concepts in the management of lobular neoplasia.

Anderson BO, Calhoun KE, Rosen EL.

J Natl Compr Canc Netw. 2006 May;4(5):511-22. Review.PMID: 16687097 [PubMed - indexed for MEDLINE]Related articles

Premalignant and in situ breast disease: biology and clinical implications.

Arpino G, Laucirica R, Elledge RM.

Ann Intern Med. 2005 Sep 20;143(6):446-57.PMID: 16172443 [PubMed - indexed for MEDLINE]Related articlesFree article

Premalignant and malignant disease of the breast: the roles of the pathologist.

Page DL, Jensen RA, Simpson JF.

Mod Pathol. 1998 Feb;11(2):120-8. Review.PMID: 9504682 [PubMed - indexed for MEDLINE]Related articles

[Current knowledge of ductal carcinoma in situ]

Böhm J, Zikán M.

Ceska Gynekol. 2009 Oct;74(5):339-47. Review. Czech. PMID: 20063837 [PubMed - indexed for MEDLINE]Related articles

[Diagnostic immunohistochemistry of breast epithelial lesions]

Balaton AJ, Guinebretière JM, Penault-Llorca F.

Ann Pathol. 2003 Dec;23(6):570-81. Review. French. PMID: 15094595 [PubMed - indexed for MEDLINE]Related articles